Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: Shenzhen
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Livzon Pharmaceutical Group Inc

+ Add to Watchlist

200513:CH

37.850 HKD 0.190 0.50%

As of 02:55:39 ET on 05/24/2013.

Company Profile for Livzon Pharmaceutical Group Inc (200513)

Livzon Pharmaceutical Group Inc. develops and manufactures pharmaceutical products, including chemical medicines, bio-chemical medicines, biological engineering medicines, chemical compound crude medicines, antibiotics, micro-ecological preparations, patent Chinese medicines, and diagnosis reagents etc.

Contact Information

Livzon Pharmaceutical Group Inc

Livzon Building, 132 Guihua
North Road, Gongbei
Zhuhai, Guangdong, 519020
China
Phone: 86-756-8135888
Fax: 86-756-8886002

Key Executives for Livzon Pharmaceutical Group Inc (200513)

Zhu BaoguoChairman/PresidentAn NingExecutive Vice President
Tao DeshengVice PresidentYang DaihongVice President
Lu WenqiVice PresidentXu GuoxiangVice President
Li RucaiSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil